Read more

November 03, 2021
1 min read
Save

Top in endocrinology: Vaccine mandates in health care, thyroid function and brain perfusion

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In a recent article, Jonathan D. Leffert, MD, spoke with a law expert about the legality of COVID-19 vaccine mandates for health care workers. It was the top story in endocrinology last week.

Another top story was about a correlation between abnormal free thyroxine levels and suboptimal cerebral blood perfusion in middle-aged and elderly adults. Both high and low thyroxine levels were found to have this effect, suggesting there is “an optimum free T4 level when considering treatment targets in hypothyroidism patients,” according to Oscar H. Roa Dueñas, MD.

Vaccine
Source: Adobe Stock

Read these and more news in endocrinology below:

Know the rules regarding COVID19 vaccine mandates for health care workers

In this issue, Leffert talks with labor and employment law expert Kim Leffert, who is his sister, about what health care practices can require of their employees with relation to COVID-19 vaccine mandates. Read more.

Abnormal free T4 associated with lower brain perfusion in adults

High and low free thyroxine levels are associated with lower global brain perfusion in adults and could lead to brain diseases, such as dementia, according to a presenter. Read more.

Exercise confers minor changes in 3 gut microbiome genera in adults with obesity

An 8-week exercise intervention was associated with improvements in insulin sensitivity and visceral adiposity in adults with obesity, with modest changes observed in three gut microbiome genera, according to study findings. Read more.

Teprotumumab effective long term during retreatment for thyroid eye disease

Teprotumumab is effective in reducing proptosis in people with thyroid eye disease more than 2 years after treatment, and initial nonresponders to teprotumumab may benefit from a second series of infusions, according to a speaker. Read more.

Returning to TI-RADS may assist with triage of indeterminate thyroid nodules

A re-analysis of thyroid imaging reporting and data system ultrasound scoring after molecular analysis is a cost-effective option to assist with preoperative diagnosis of indeterminate thyroid nodules, data from a retrospective study show. Read more.